VITAMINS, COMMON INFORMATION

22 09 2013

New Drug Approvals

A vitamin (US /ˈvtəmɪn/ or UK /ˈvɪtəmɪn/) is an organic compound required by an organism as a vital nutrient in limited amounts. An organic chemical compound (or related set of compounds) is called a vitamin when it cannot be synthesized in sufficient quantities by an organism, and must be obtained from the diet. Thus, the term is conditional both on the circumstances and on the particular organism. For example, ascorbic acid (vitamin C) is a vitamin for humans, but not for most other animals, and biotin (vitamin H) and vitamin D are required in the human diet only in certain circumstances.

 

 

 

 

Thiamin

What it does:

  • helps convert…

View original post 1,230 more words

Advertisements




GLENMARK- ELOVERA , for dry skin disorders

19 09 2013

New Drug Approvals

Compositions:
Elovera extract 10% cream, Vitamin E 0.5%

Category–Locally Acting Skin Preparations

Description

* Aqueeze adequate amount of elovera moisturizing body wash onto wet hands or wet loran and work into a creamy lather. apply it all ovr the body, keep for some time and then rinse with water.

http://www.drugneed.com/glenmark-pharmaceuticals-elovera-moisturizing-body-wash-150ml-glenmak-p-2017.html#tab4

Products Name : Elovera Moisturizing Body Wash 150ml – (Glenmark)

 

Elovera Cream, manufacture by Glenmark pharmaceuticals limited , is cream enriched with vitamin E and Aloe Vera. It’s a very special cream specially for treating scars and other minor pimple spots on the face.

reviews from net

My skin is very much oily hence I get these ugly Pimples very profoundly. On top of it i have the habit of bursting out the puss from these pimples. I always play it with my hands and as a result forms some very ugly scars on my face which are visible…

View original post 198 more words





Forigerimod, (Rigerimod) also known as Lupuzor, CEP-3345 for treatment of systemic lupus erythematosus (SLE)

19 09 2013

New Drug Approvals

FORIGERIMOD

CHEMICAL NAMES
1. L-Tyrosine, L-arginyl-L-isoleucyl-L-histidyl-L-methionyl-L-valyl-L-tyrosyl-L-seryl-L-lysyl-L-arginyl-O-phosphono-L-serylglycyl-L-lysyl-L-prolyl-L-arginylglycyl-L-tyrosyl-L-alanyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-
2. O3,140-phosphono(human U1 small nuclear ribonucleoprotein 70 kDa (snRNP70))-(131-151)-peptide

MOLECULAR FORMULA C117H181N34O32PS
MOLECULAR WEIGHT 2639
TRADEMARK Lupuzor
SPONSOR Cephalon, Inc.
CODE DESIGNATION IPP 201101
CAS REGISTRY NUMBER 497156-60-2

STRUCTURAL FORMULA

stucture, http://www.ama-assn.org/ama1/pub/upload/mm/365/forigerimod.pdf

  1. Forigerimod nonproprietary drug name

    STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL. USAN. FORIGERIMOD.

    …………………………………………………………………………………………………………..

    FORIGERIMOD ACETATE

    CAS REGISTRY NUMBER 1160237-55-7  of acetate

    http://www.ama-assn.org/resources/doc/usan/forigerimod-acetate.pdf

     

  2. Forigerimod acetate nonproprietary drug name

    STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL. USAN. FORIGERIMOD ACETATE

    str is
    FORIGERIMOD ACETATE

Forigerimod, also known as Lupuzor or CEP-33457, (SyB L-1001) is a CD4 T-cell modulator being investigated for the treatment of systemic lupus erythematosus (SLE). In the Phase II trials, Lupuzor was administered subcutaneously at a dose of 200 mcg once a month for 3 months. The Phase III study is anticipated to…

View original post 534 more words





FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia

19 09 2013

New Drug Approvals

LONDON, Sept. 18, 2013 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for EpanovaTM, an investigational compound for the treatment for patients with severe hypertriglyceridaemia (triglyceride levels greater than or equal to 500mg/dL). The NDA submission for Epanova was filed by Omthera Pharmaceuticals, now a wholly-owned subsidiary of AstraZeneca, as a 505(b)(1) application in July 2013. The Prescription Drug User Fee Act (PDUFA) goal date for the FDA is 5 May 2014.http://www.pharmalive.com/fda-accepts-astrazeneca-nda-for-epanova

View original post





FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia

19 09 2013

New Drug Approvals

LONDON, Sept. 18, 2013 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for EpanovaTM, an investigational compound for the treatment for patients with severe hypertriglyceridaemia (triglyceride levels greater than or equal to 500mg/dL). The NDA submission for Epanova was filed by Omthera Pharmaceuticals, now a wholly-owned subsidiary of AstraZeneca, as a 505(b)(1) application in July 2013. The Prescription Drug User Fee Act (PDUFA) goal date for the FDA is 5 May 2014.http://www.pharmalive.com/fda-accepts-astrazeneca-nda-for-epanova

View original post





FDA OKs Teva’s Injectable Treanda

19 09 2013

New Drug Approvals

FDA OKs Teva’s Injectable Treanda

FDA Approves Teva’s Injectable Treanda

bendamustine

Sept. 17, 2013 (GLOBES)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced that the US Food and Drug Administration (FDA) has approved a new injectable version Treanda for treatment of indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen, and chronic lymphocytic leukemia. read all at

http://www.pharmalive.com/fda-oks-tevas-injectable-treanda

Bendamustine (INN, trade names TreakisymRibomustinLevact and Treanda; also known as SDX-105) is a nitrogen mustard used in the treatment of chronic lymphocytic leukemia[1] and lymphomas. It belongs to the family of drugs called alkylating agents. It is also being studied for the treatment of sarcoma.[2]

History

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany(the former German Democratic Republic). Until 1990 it…

View original post 2,964 more words





Niche play, alliances hold promise for Biocon

8 09 2013

New Drug Approvals

 DR KIRAN SHAW MAXUMDAR

MD BIOCON

Niche play, alliances hold promise for Biocon

While biosimilar opportunity in the regulated markets is likely to play out in the medium term, its existing biopharma and branded portfolio will ensure growth in the short term

Niche play, alliances hold promise for Biocon
Business Standard
Innovator sales for these two drugs are pegged at $10 billion which is slightly over half of the worldwide insulin market of $19 billion.On the monoclonal antibody front, the company is in phase III for the cancer drug Trastuzumab which has a market

READ ALL THIS AT

http://www.business-standard.com/article/companies/niche-play-alliances-hold-promise-for-biocon-113090500095_1.html

 

View original post








Green Chemistry @ MUN

Less solvent, Less waste, Less energy

Inspiring Science

Casting light on great ideas

Your mom is like science?

Practical scientific analogy education and outreach

DRUG REGULATORY AFFAIRS INTERNATIONAL

Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Syntheticnature

Total Synthesis and general organic chemistry

pharmupdates.wordpress.com/

News and articles on the Pharmaceutical Industry

Combinatorics and more

Gil Kalai's blog

Organic chemistry teaching

Just another WordPress.com weblog

Seven Spheres

Aqua Terra Ignis et Aer

The Molecular Circus

How molecules make the world go round

Chemtips

Because Organic Chemistry is Hard Enough

The Heterocyclist

A blog about heterocyclic chemistry

travellingbeets

Travelling Stories & Photographs From One Travel Lover To Another

The Sacred Lives of Objects

Seeing and Being Seen in the Modern Museum

Earth mY homE

Seeing the Surroundings

One Person, One World.

Tibet, Human Rights, Injustice, Animal Abuse, Child Abuse

France Outdoors

Experience Culture, Physical Activity and Nature on Every Trip

Grind Your Wheat

a chronicle of our nomadic wanderings

Green Chemistry @ MUN

Less solvent, Less waste, Less energy

Inspiring Science

Casting light on great ideas

Your mom is like science?

Practical scientific analogy education and outreach

DRUG REGULATORY AFFAIRS INTERNATIONAL

Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Syntheticnature

Total Synthesis and general organic chemistry

pharmupdates.wordpress.com/

News and articles on the Pharmaceutical Industry

Combinatorics and more

Gil Kalai's blog

Organic chemistry teaching

Just another WordPress.com weblog

Seven Spheres

Aqua Terra Ignis et Aer

The Molecular Circus

How molecules make the world go round

Chemtips

Because Organic Chemistry is Hard Enough

The Heterocyclist

A blog about heterocyclic chemistry

travellingbeets

Travelling Stories & Photographs From One Travel Lover To Another

The Sacred Lives of Objects

Seeing and Being Seen in the Modern Museum

Earth mY homE

Seeing the Surroundings

One Person, One World.

Tibet, Human Rights, Injustice, Animal Abuse, Child Abuse

France Outdoors

Experience Culture, Physical Activity and Nature on Every Trip

Grind Your Wheat

a chronicle of our nomadic wanderings

Green Chemistry @ MUN

Less solvent, Less waste, Less energy

Inspiring Science

Casting light on great ideas

Your mom is like science?

Practical scientific analogy education and outreach

DRUG REGULATORY AFFAIRS INTERNATIONAL

Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Syntheticnature

Total Synthesis and general organic chemistry

pharmupdates.wordpress.com/

News and articles on the Pharmaceutical Industry

Combinatorics and more

Gil Kalai's blog

Organic chemistry teaching

Just another WordPress.com weblog

Seven Spheres

Aqua Terra Ignis et Aer

The Molecular Circus

How molecules make the world go round

Chemtips

Because Organic Chemistry is Hard Enough

The Heterocyclist

A blog about heterocyclic chemistry

travellingbeets

Travelling Stories & Photographs From One Travel Lover To Another

The Sacred Lives of Objects

Seeing and Being Seen in the Modern Museum

Earth mY homE

Seeing the Surroundings

One Person, One World.

Tibet, Human Rights, Injustice, Animal Abuse, Child Abuse

France Outdoors

Experience Culture, Physical Activity and Nature on Every Trip

Grind Your Wheat

a chronicle of our nomadic wanderings

%d bloggers like this: